WhitTier Trust Company’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299 Sell
12
-12
-50% -$281 ﹤0.01% 1385
2026
Q1
$332 Hold
24
﹤0.01% 1373
2025
Q4
$282 Hold
24
﹤0.01% 1247
2025
Q3
$282 Hold
24
﹤0.01% 1248
2025
Q2
$292 Hold
24
﹤0.01% 1407
2025
Q1
$341 Hold
24
﹤0.01% 1377
2024
Q4
$381 Hold
24
﹤0.01% 1306
2024
Q3
$576 Hold
24
﹤0.01% 1287
2024
Q2
$476 Hold
24
﹤0.01% 1229
2024
Q1
$476 Hold
24
﹤0.01% 1184
2023
Q4
$537 Hold
24
﹤0.01% 1173
2023
Q3
$484 Hold
24
﹤0.01% 1132
2023
Q2
$612 Hold
24
﹤0.01% 1144
2023
Q1
$712 Hold
24
﹤0.01% 1125
2022
Q4
$648 Hold
24
﹤0.01% 1155
2022
Q3
$0 Hold
24
﹤0.01% 1091
2022
Q2
$0 Sell
24
-6
-20% -$172 ﹤0.01% 1119
2022
Q1
$1K Hold
30
﹤0.01% 1077
2021
Q4
$1K Hold
30
﹤0.01% 1037
2021
Q3
$1K Sell
30
-50
-63% -$1.7K ﹤0.01% 1087
2021
Q2
$3K Hold
80
﹤0.01% 947
2021
Q1
$4K Hold
80
﹤0.01% 920
2020
Q4
$4K Hold
80
﹤0.01% 899
2020
Q3
$3K Hold
80
﹤0.01% 907
2020
Q2
$3K Hold
80
﹤0.01% 880
2020
Q1
$2K Sell
80
-27
-25% -$806 ﹤0.01% 929
2019
Q4
$4K Hold
107
﹤0.01% 934
2019
Q3
$4K Buy
107
+18
+20% +$687 ﹤0.01% 927
2019
Q2
$4K Sell
89
-75
-46% -$3.21K ﹤0.01% 924
2019
Q1
$7K Hold
164
﹤0.01% 870
2018
Q4
$7K Hold
164
﹤0.01% 874
2018
Q3
$11K Hold
164
﹤0.01% 808
2018
Q2
$9K Sell
164
-62
-27% -$3.28K ﹤0.01% 823
2018
Q1
$10K Buy
226
+84
+59% +$3.99K ﹤0.01% 834
2017
Q4
$7K Sell
142
-50
-26% -$2.3K ﹤0.01% 828
2017
Q3
$9K Hold
192
﹤0.01% 795
2017
Q2
$8K Buy
192
+50
+35% +$1.89K ﹤0.01% 776
2017
Q1
$5K Sell
142
-261
-65% -$10.2K ﹤0.01% 839
2016
Q4
$15K Hold
403
﹤0.01% 718
2016
Q3
$14K Sell
403
-18
-4% -$630 ﹤0.01% 730
2016
Q2
$13K Sell
421
-46
-10% -$1.41K ﹤0.01% 736
2016
Q1
$13K Sell
467
-93
-17% -$2.48K ﹤0.01% 738
2015
Q4
$19K Buy
560
+17
+3% +$529 ﹤0.01% 681
2015
Q3
$15K Sell
543
-182
-25% -$6.35K ﹤0.01% 727
2015
Q2
$29K Sell
725
-237
-25% -$10.6K ﹤0.01% 630
2015
Q1
$48K Sell
962
-755
-44% -$35K 0.01% 536
2014
Q4
$78K Buy
+1,717
New +$67.5K 0.01% 469

Other funds holding AVNS

WhitTier Trust Company's AVNS Position: Q2 2026 in Review

WhitTier Trust Company reduced its Avanos Medical (AVNS) stake by 50% in Q2 2026, selling an estimated $281 and leaving 12 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

WhitTier Trust Company first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $78K in Q4 2014. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • WhitTier Trust Company held 12 shares of Avanos Medical worth $299 as of Q2 2026.
  • WhitTier Trust Company sold 12 Avanos Medical shares in Q2 2026, an estimated $281.
  • Avanos Medical made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1385 holding.
  • WhitTier Trust Company first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • WhitTier Trust Company's Avanos Medical position peaked at $78K in Q4 2014.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.